Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 7,761,336 | 7,494,876 | 6,718,368 | 7,950,268 | 7,497,660 |
| Cost of Goods | 3,360,187 | 3,128,998 | 2,935,921 | 3,178,381 | 3,352,869 |
| Gross Profit | 4,401,149 | 4,365,878 | 3,782,447 | 4,771,888 | 4,144,791 |
| Operating Expenses | 2,761,583 | 2,695,456 | 2,722,609 | 3,029,375 | 2,749,143 |
| Operating Income | 1,639,753 | 1,671,420 | 1,060,759 | 1,742,896 | 1,396,517 |
| Interest Expense | 96,199 | 136,969 | 124,190 | 178,470 | 69,701 |
| Other Income | 327,821 | 32,587 | 995,910 | 121,780 | 46,220 |
| Pre-tax Income | 1,871,375 | 1,567,038 | 1,932,479 | 1,686,206 | 1,373,036 |
| Income Tax | 391,008 | 278,933 | 493,842 | 296,483 | 288,424 |
| Net Income Continuous | 1,480,367 | 1,288,105 | 1,438,637 | 1,389,723 | 1,084,612 |
| Net Income | $1,480,367 | $1,288,105 | $1,438,637 | $1,536,226 | $1,084,612 |
| EPS Basic Total Ops | 0.95 | 0.83 | 0.93 | 0.99 | 0.70 |
| EPS Basic Continuous Ops | 0.96 | 0.83 | 0.93 | 0.89 | 0.70 |
| EPS Diluted Total Ops | 0.95 | 0.83 | 0.92 | 0.98 | 0.69 |
| EPS Diluted Continuous Ops | 0.95 | 0.83 | 0.92 | 0.88 | 0.69 |
| EBITDA(a) | $2,180,467 | $2,208,818 | $1,524,804 | $2,165,448 | $1,895,077 |